Skip to main content
Clinical Trials/NCT03897192
NCT03897192
Completed
Not Applicable

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Changhua Christian Hospital1 site in 1 country14 target enrollmentOctober 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Punctate Inner Choroidopathy
Sponsor
Changhua Christian Hospital
Enrollment
14
Locations
1
Primary Endpoint
Wilcoxon Signed-Rank test
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

To report the long term prognosis in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR).

Registry
clinicaltrials.gov
Start Date
October 1, 2018
End Date
March 20, 2019
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

San Ni Chen

Department of Ophthalmology

Changhua Christian Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR).
  • Follow up over 4 years.

Exclusion Criteria

  • Patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) without zonal outer retinopathy (ZOR).

Outcomes

Primary Outcomes

Wilcoxon Signed-Rank test

Time Frame: Baseline, 4 year

A statistical comparison of average of different time point

Secondary Outcomes

  • visual acuity(Baseline, 6 month, 12 month, 24 month, 36 month, 48 month)

Study Sites (1)

Loading locations...

Similar Trials